TrialJournal of neuro-oncology2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.
Vihang Nakhate et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it